11/12/24 8:46 AM
c-LEcta's NuCLEANase Receives Positive GRAS Evaluation from US FDA
After submitting a GRAS notification for NuCLEANase (GRN No.1146) to the US FDA, c-LEcta has...
read more
9/17/24 8:31 AM
c-LEcta celebrates 20 years of innovation
The biotech pioneer celebrates with employees and guests with live music and a varied program.
read more
7/30/24 11:25 AM
Upcoming Webinar: Salt-tolerant endonucleases and the benefits for viral vector manufacturing, and a comparison of two marketed enzymes
Tuesday 27th August 202408:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST Live30 webinars are...
read more
7/2/24 9:51 AM
Change in Management
Thomas Pfaadt will leave c-LEcta on 31 July 2024 and devote himself to a new professional challenge...
read more
4/18/24 8:57 AM
OFB and c-LEcta celebrate topping-out ceremony for "BioSquare Leipzig"
OFB Projektentwicklung GmbH has reached another milestone on the way to the completion of the first...
read more
3/5/24 8:35 AM
c-LEcta Launches DENARASE® High Salt for Enhanced Process Flexibility in Viral Vector Manufacturing
c-LEcta, a leading international supplier of enzymes for the biopharmaceutical industry announces...
read more
2/27/24 8:51 AM
Introducing Acrylerase®: an innovative enzymatic solution to reduce acrylamide levels in soluble coffee products
c-LEcta and ANKA have developed Acrylerase® - a new food enzyme to reduce acrylamide in instant...
read more
1/9/24 9:29 AM
Successful year for NuCLEANase
c-LEcta grows revenue and worldwide customer base of its new enzymatic technology with regulatory...
read more
12/13/23 8:41 AM
Our year 2023 in review
The year is coming to an end! It was another eventful year that allowed us to make progress, both...
read more
9/20/23 9:15 AM
Analytics first - What does an analytical chromatography specialist do?
Analyses are one of the core tasks in enzyme development and are required in almost every project....
read more